Sudeep Pharma Ltd

NSE: SUDEEPPHRM BSE: 544619Pharma

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.[1]

₹647

52W: ₹524 — ₹796

PE 71.7 · Book ₹57.1 · +1033% vs book

Market Cap₹7,306 Cr

Stock P/E71.7Price to Earnings

ROCE28.6%Return on Capital

ROE25.1%Return on Equity

Div. Yield0%Face Value ₹1

Strengths

+Company has a good return on equity (ROE) track record: 3 Years ROE 30.0%

Weaknesses

−Stock is trading at 11.2 times its book value
−Though the company is reporting repeated profits, it is not paying out dividend
−Company has high debtors of 166 days.

Shareholding Pattern

Promoters76.16%

FIIs1.55%

DIIs18.11%

Public4.18%

Category	Dec 2025	Mar 2026
Promoters	76.16%	76.16%
FIIs	1.67%	1.55%▼0.1
DIIs	17.59%	18.11%▲0.5
Public	4.57%	4.18%▼0.4

Financial Statements

Metric	Dec 2024	Sep 2025	Dec 2025
Sales	83	88	90
Expenses	57	57	61
Operating Profit	26	31	30
OPM %	32%	35%	33%
Net Profit	21	30	27
EPS ₹	2.12	3.06	2.38

AI Insights

Revenue Trend

Mar 2025 revenue at ₹357Cr, up 3.8% YoY. OPM at 37%.

Debt Position

Borrowings at ₹114Cr. Debt-to-equity ratio: 0.18x. Healthy balance sheet.

Capex Cycle

CWIP at ₹116Cr (113% of fixed assets). Significant capex underway — growth runway building.

Margin & Efficiency

ROCE improving from 0% (Mar 2021) to 29% (Mar 2025). Working capital days: 140.

Valuation

PE 71.7x with 28.6% ROCE. Price is 1033% above book value of ₹57.1. Dividend yield: 0%.